Pharsight

Drugs that contain Metaxalone

1. Skelaxin patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7122566 KING PHARMS Metaxalone products, method of manufacture, and method of use
Feb, 2026

(1 year, 11 months from now)

Market Authorisation Date: 30 August, 2002

Treatment: Treatment of musculoskeletal conditions

Dosage: TABLET;ORAL

How can I launch a generic of SKELAXIN before it's drug patent expiration?
More Information on Dosage

SKELAXIN family patents

Family Patents